Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Federal government shutdown stalled 100 medical device submissions
Mass Device
Friday, November 1, 2013 - 9:53am
tags:
devices
Cheaper By The Dozen? J&J Is Sued Over 340B Drug Discounts
Pharmalot
Friday, November 1, 2013 - 9:51am
tags:
JNJ, 340B, drug discounts
Gentium: Posts Strong Q3 Beat And Remains Attractive
Seeking Alpha
Friday, November 1, 2013 - 9:40am
tags:
Gentium, earnings
Is A Storm Brewing At Teva?
Seeking Alpha
Friday, November 1, 2013 - 9:40am
tags:
Teva
Zalicus announces Z944 Phase 1b clinical study positive results
Yahoo/Fly on the Wall
Friday, November 1, 2013 - 9:25am
tags:
Zalicus, Z944
U.S. FDA outlines plan to combat drug shortages
Yahoo/Reuters
Friday, November 1, 2013 - 8:39am
tags:
FDA, drug shortages
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Motley Fool
Friday, November 1, 2013 - 8:38am
tags:
patents, Amgen, Neupogen, Merck KGaA, Rebif, Cymbalta, Eli Lilly
Analysis: For Merck, bringing cattle feed Zilmax back won't be easy
Yahoo/Reuters
Friday, November 1, 2013 - 8:34am
tags:
Merck, Zilmax, animal health
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Forbes
Friday, November 1, 2013 - 8:28am
tags:
Pfizer, PCSK9 inhibitors, RN-316, Sanofi, Regeneron, REGN727, AMG145, Amgen
2 Drug Promotions Going in Opposite Directions
Motley Fool
Friday, November 1, 2013 - 8:26am
tags:
Amarin, Vascepa, Arena Pharmaceuticals, Eisai
Judge Invalidates Patent for a Down Syndrome Test
NY Times, NY
Friday, November 1, 2013 - 8:23am
tags:
Downs Syndrome, patents, Sequenom
Clovis Oncology's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Seeking Alpha
Friday, November 1, 2013 - 8:22am
tags:
earnings, Clovis Oncology
Uh Oh Arena Pharma! Q3 Belviq Sales Just $4.8M
TheStreet.com
Friday, November 1, 2013 - 8:20am
tags:
Arena Pharmaceuticals, Belviq, Eisai, obesity
Novo Nordisk recruiting 400 U.S. sales reps as growth decelerates
Fierce Pharma
Thursday, October 31, 2013 - 11:36am
tags:
hirings, Novo Nordisk
Bayer Third-Quarter Earnings Rise on New Medicines
Bloomberg
Thursday, October 31, 2013 - 11:33am
tags:
earnings, Bayer
Mazor Robotics prices $41M offering
Mass Device
Thursday, October 31, 2013 - 11:32am
tags:
Mazor Robotics, stock offering, devices
Smith & Nephew names new chairman, posts Q3 profit slip
Mass Device
Thursday, October 31, 2013 - 11:31am
tags:
Smith & Nephew, earnings, devices
Reckitt Heroin-Abuse Drug Seen Luring Shire: Real M&A
Bloomberg
Thursday, October 31, 2013 - 11:30am
tags:
Reckitt Benckiser, heroin abuse, Shire, M&A, Suboxone, Actavis
New two-hormone Roche drug shows promise in diabetes, obesity
Reuters
Thursday, October 31, 2013 - 11:29am
tags:
Roche, obesity, diabetes, GLP-1 agonist
Drug-maker Valeant eyes small and large M&A deals
Reuters
Thursday, October 31, 2013 - 11:23am
tags:
M&A, Valeant Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.